acrylonitrile has been researched along with Malignant Melanoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Aluru, JS; Barsouk, A; Rawla, P; Saginala, K | 1 |
| Mahabadi, AA; Michel, L; Mincu, RI; Mrotzek, SM; Rassaf, T; Schadendorf, D; Totzeck, M | 1 |
| Comet, A; Denis, D; Ramtohul, P | 1 |
| Blagg, BSJ; Chanda, M; Cohen, MS; Sanchez, JN; Shanguan, G; Subramanian, C; Timmermann, BN; Wang, T; Zhang, N | 1 |
| Berking, C; Heppt, MV; Steeb, T; Wessely, A | 1 |
| Boulinguez, S; Lamant, L; Lucas, P; Meyer, N; Mourey, L; Paul, C; Sibaud, V | 1 |
| Chee, N; Min, MS; Sapadin, AN; Shim-Chang, H; Yao, J | 1 |
| Chan, J; Corrie, P; di Pietro, M; Fitzgerald, RC; Januszewicz, W; Liu, H | 1 |
| Basu, TN; Fearfield, L; Gore, ME; Larkin, JM; Mortimer, PS; Thomas, CL | 1 |
| Cossu, I; Dono, M; Gualco, M; Manzini, C; Mingari, MC; Moretta, L; Pietra, G; Queirolo, P; Spagnolo, F; Venè, R; Zupo, S | 1 |
| Abuodeh, YA; Ahmed, KA; Arrington, JA; Caudell, JJ; Echevarria, MI; Etame, AB; Forsyth, PA; Harrison, LB; Hogue, C; Johnstone, PA; Khushalani, NI; Kim, S; Kim, Y; Naghavi, AO; Patel, BG; Sahebjam, S; Sarangkasiri, S; Stallworth, DG; Yu, M | 1 |
| Johnson, D | 1 |
| Babovic, N; Banjin, M; Bastholt, L; Blank, C; Bylaite-Bucinskiene, M; De La Cruz Merino, L; Demidov, L; Dummer, R; Forsea, AM; Garbe, C; Gogas, H; Grob, JJ; Hansson, J; Hauschild, A; Herceg, D; Hoeller, C; Kandolf Sekulovic, L; Kirov, K; Krajsova, I; Kukushkina, M; Lebbe, C; Maric-Brozic, J; Nathan, P; Neyns, B; Ocvirk, J; Olah, J; Peris, K; Putnik, K; Risteski, M; Rutkowski, P; Stratigos, A; Todorovic, V; Vieira, R; Weinlich, G; Ymeri, A; Zalaudek, I; Zhukavets, A | 1 |
3 review(s) available for acrylonitrile and Malignant Melanoma
| Article | Year |
|---|---|
Epidemiology of Melanoma.
Topics: Acrylonitrile; Aged; Aniline Compounds; Humans; Immune Checkpoint Inhibitors; Incidence; Melanoma; Monitoring, Immunologic; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sunscreening Agents; United States | 2021 |
Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis.
Topics: Acrylonitrile; Adult; Aged; Aged, 80 and over; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Female; Humans; Male; Melanoma; Middle Aged; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Randomized Controlled Trials as Topic; Skin Neoplasms; Young Adult | 2019 |
How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance.
Topics: Acrylonitrile; Aniline Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Differentiation; Cell Movement; Cell Plasticity; Drug Resistance, Neoplasm; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Melanocytes; Melanoma; Microphthalmia-Associated Transcription Factor; MSX1 Transcription Factor; Neural Crest; PAX3 Transcription Factor; Phenotype; Pyrimidinones; Skin Neoplasms; SOXE Transcription Factors | 2021 |
10 other study(ies) available for acrylonitrile and Malignant Melanoma
| Article | Year |
|---|---|
Kinetics of Punctate Subretinal Deposits in Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy Using En Face Optical Coherence Tomography.
Topics: Acrylonitrile; Adult; Aniline Compounds; Carbamates; Extracellular Signal-Regulated MAP Kinases; Fluorescein Angiography; Fundus Oculi; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Mitogen-Activated Protein Kinases; Retina; Retinal Diseases; Skin Neoplasms; Subretinal Fluid; Sulfonamides; Tomography, Optical Coherence | 2021 |
A novel C-terminal Hsp90 inhibitor KU758 synergizes efficacy in combination with BRAF or MEK inhibitors and targets drug-resistant pathways in BRAF-mutant melanomas.
Topics: Acrylonitrile; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; HSP90 Heat-Shock Proteins; Humans; Melanoma; Proto-Oncogene Proteins B-raf; Survival Analysis | 2021 |
Characterization and Outcomes of Disease Progression in 52 Patients Treated with BRAF-V600 + MEK Inhibitors for Advanced Melanoma.
Topics: Acrylonitrile; Aged; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Azetidines; Disease Progression; Female; Humans; Male; MAP Kinase Kinase 1; Melanoma; Middle Aged; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Vemurafenib | 2018 |
Xanthogranulomatous reaction to trametinib for metastatic malignant melanoma.
Topics: Acrylonitrile; Aged; Aniline Compounds; Antineoplastic Agents; Diagnosis, Differential; Granuloma; Humans; Male; Melanoma; Neoplasm Staging; Pyridones; Pyrimidinones; Skin Neoplasms; Xanthomatosis | 2018 |
A sinister black finding in the stomach.
Topics: Acrylonitrile; Aged; Aniline Compounds; Barrett Esophagus; Benzimidazoles; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Melanoma; Mutation; Neoplasm Metastasis; Paclitaxel; Prognosis; Stomach; Tomography, X-Ray Computed; Tubulin Modulators; Uveal Neoplasms | 2019 |
A mitogen-activated protein kinase kinase inhibitor induced compound skin toxicity with oedema in metastatic malignant melanoma.
Topics: Acrylonitrile; Adult; Aniline Compounds; Edema; Female; Humans; Male; Melanoma; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Protein Kinase Inhibitors; Skin Diseases; Skin Neoplasms | 2016 |
Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function.
Topics: Acrylonitrile; Aniline Compounds; Antineoplastic Agents; Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diphenylamine; Down-Regulation; Flow Cytometry; Humans; Immunotherapy; Indoles; Interleukin-15; Interleukin-2; Killer Cells, Natural; Melanoma; Neoplasm Recurrence, Local; Oncogenes; Proto-Oncogene Proteins B-raf; Signal Transduction; Skin Neoplasms; Sulfonamides; Vemurafenib | 2016 |
Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy.
Topics: Acrylonitrile; Adolescent; Adult; Aged; Aged, 80 and over; Aniline Compounds; Brain Neoplasms; Combined Modality Therapy; CTLA-4 Antigen; Disease-Free Survival; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prognosis; Programmed Cell Death 1 Receptor; Proto-Oncogene Proteins B-raf; Radiosurgery | 2016 |
Is there a role for single-agent MEK inhibition in melanoma?
Topics: Acrylonitrile; Aniline Compounds; Humans; MAP Kinase Kinase 1; Melanoma | 2016 |
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.
Topics: Acrylonitrile; Aniline Compounds; Antibodies, Monoclonal, Humanized; Europe; Female; Health Services Accessibility; Healthcare Disparities; Humans; Immunotherapy; Male; Melanoma; Programmed Cell Death 1 Receptor; Proto-Oncogene Proteins B-raf; Reimbursement Mechanisms; Skin Neoplasms; Therapies, Investigational | 2017 |